Literature DB >> 21690529

Surveillance of patients for early detection of melanoma: patterns in dermatologist vs patient discovery.

Sean T McGuire1, Aaron M Secrest, Ryan Andrulonis, Laura K Ferris.   

Abstract

OBJECTIVE: To determine which groups of patients are most and least likely to detect their own melanomas independent of dermatologist evaluation.
DESIGN: Retrospective analysis.
SETTING: Academic dermatology department from January 1, 2003, through December 31, 2008. PATIENTS: One hundred sixty-seven consecutive patients with incident biopsy-confirmed melanomas. MAIN OUTCOME MEASURES: Proportion of melanomas found on dermatologist examination vs those brought to the attention of the examining dermatologist by the patient. Secondary analysis examined associations between who detected the melanoma (dermatologist vs patient) and patient age, personal history of skin cancer, family history of melanoma, and depth of lesion.
RESULTS: Of the 167 melanomas, 101 (60.5%) were brought to the attention of the dermatologist by the patient. Detection by a dermatologist was significantly associated with patient age of 50 years or older (P = .002), personal skin cancer history (P < .001), and a lesion depth of less than 0.75 mm at the time of detection (P = .03). Only 3.0% of all melanomas in this study were detected by dermatologists in patients who had a low baseline risk of melanoma (age <50 years, no personal history of skin cancer, and no family history of melanoma). These patients were much more likely to detect their own melanoma (odds ratio, 7.32 [95% confidence interval, 2.69-19.90]).
CONCLUSIONS: Screening for melanoma in asymptomatic patients younger than 50 years with no medical history of skin cancer or family history of melanoma yields few physician-detected melanomas because these patients are most likely to detect their melanomas themselves. Screening and surveillance efforts should focus on patients 50 years or older and those with a personal history of skin cancer or a family history of melanoma.

Entities:  

Mesh:

Year:  2011        PMID: 21690529     DOI: 10.1001/archdermatol.2011.135

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; Jeanne M Ferrante; Eduardo C Gonzalez; Ren Chen; Kate J Fisher; Kymia Love-Jackson; Ellen P McCarthy
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

2.  Diagnostic inaccuracy of smartphone applications for melanoma detection.

Authors:  Joel A Wolf; Jacqueline F Moreau; Oleg Akilov; Timothy Patton; Joseph C English; Jonhan Ho; Laura K Ferris
Journal:  JAMA Dermatol       Date:  2013-04       Impact factor: 10.282

3.  Low accuracy of self-reported family history of melanoma in high-risk patients.

Authors:  Nicholas D Flint; Michael D Bishop; Tristan C Smart; Jennifer L Strunck; Kenneth M Boucher; Douglas Grossman; Aaron M Secrest
Journal:  Fam Cancer       Date:  2021-01       Impact factor: 2.375

Review 4.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

Review 5.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

6.  Landmark Series on Disparities in Surgical Oncology: Melanoma.

Authors:  Elliot A Asare; Umang Swami; John H Stewart
Journal:  Ann Surg Oncol       Date:  2021-06-30       Impact factor: 5.344

7.  Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis.

Authors:  Anthony J Chiaravalloti; Jeffrey R Laduca
Journal:  J Clin Aesthet Dermatol       Date:  2014-08

8.  Skin cancer knowledge and attitudes in the region of Fez, Morocco: a cross-sectional study.

Authors:  Awatef Kelati; Hanane Baybay; Mariam Atassi; Samira Elfakir; Salim Gallouj; Mariame Meziane; Fatima Zahra Mernissi
Journal:  BMC Dermatol       Date:  2017-02-17

9.  Can Dermoscopy Be Used to Predict if a Melanoma Is In Situ or Invasive?

Authors:  Sam Polesie; Edvin Jergéus; Martin Gillstedt; Hannah Ceder; Johan Dahlén Gyllencreutz; Julia Fougelberg; Eva Johansson Backman; Jenna Pakka; Oscar Zaar; John Paoli
Journal:  Dermatol Pract Concept       Date:  2021-05-20

10.  Analyzing Controversies in Management and Surveillance of Early-Stage Melanoma.

Authors:  Olga Marushchak; Ezra Hazan; David A Kriegel
Journal:  Oncol Ther       Date:  2020-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.